Cartridge-based nucleic amplification (CBNAAT)/GeneXpert test as a diagnostic modality for the detection of genital tuberculosis in women with infertility
GMS Infectious Diseases · 11.07.2025 · 13 (Doc03)
DOI: 10.3205/id000093 ↗Kurz gefasst
Fachartikel in der Zeitschrift GMS Infectious Diseases, erschienen am 11.07.2025. Verfasst von Chavini K Shaozae und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Lady Hardinge Medical College and Associated SSK and KSC Hospitals, New Delhi, India. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Genital tuberculosis (GTB) is a significant etiological factor of infertility in developing countries such as India; however, it is frequently undiagnosed due to its asymptomatic nature and a lack of standardised protocols. This study aimed to compare the diagnostic efficacy of GeneXpert (CBNAAT) with Ziehl-Neelsen (ZN) staining, Mycobacterial Growth Indicator Tube (MGIT) liquid culture and histopathological examination (HPE). Additionally, the occurrence of GTB in infertile women aged between 18 and 45 years was also determined.
Methods
The study comprised 200 infertile women with suspected GTB. Endometrial biopsy samples were collected aseptically and subjected to ZN staining, MGIT liquid culture, GeneXpert testing and HPE and the results were analysed and compared. MGIT was considered the gold standard test in accordance with National TB Elimination Programme (NTEP) recommendations.
Results
There were 164 (82%) cases of primary infertility, and 36 (18%) cases of secondary infertility. Out of the 200 samples of endometrial biopsy (EB) specimens, the GeneXpert test detected two positive findings (1%), ZN staining detected two positive results (1%), and MGIT liquid culture as well as HPE detected one positive result (0.5%). GeneXpert demonstrated a sensitivity of 100% (confidence interval (CI) 2.50–100.00%), a specificity of 99.5% (CI 97.23–99.99%), a positive predictive value (PPV) of 50% (CI 12.40–87.60%), and a negative predictive value (NPV) of 100% (CI 98.15–100.00%), with liquid culture as reference. A significant agreement was found between the diagnostic procedures of MGIT and GeneXpert, with a kappa value of 0.66 and a p-value of 0.047 (significant p-value
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, Lady Hardinge Medical College and Associated SSK and KSC Hospitals, New Delhi, India.
- Department of Obstetrics and Gynaecology, Lady Hardinge Medical College and Associated SSK and KSC Hospitals, New Delhi, India.
Zitieren
APA
Shaozae, C. K., Rai, Y., Jaiswal, N., & Jais, M. B. (2025). Cartridge-based nucleic amplification (CBNAAT)/GeneXpert test as a diagnostic modality for the detection of genital tuberculosis in women with infertility. GMS Infectious Diseases, 13(Doc03). https://doi.org/10.3205/id000093
Vancouver
Shaozae CK, Rai Y, Jaiswal N, Jais MB. Cartridge-based nucleic amplification (CBNAAT)/GeneXpert test as a diagnostic modality for the detection of genital tuberculosis in women with infertility. GMS Infectious Diseases. 2025;13(Doc03). doi:10.3205/id000093
BibTeX
@article{Shaozae2025,
author = {Shaozae, Chavini K and Rai, Yogita and Jaiswal, Nishtha and Jais, Manoj B},
title = {Cartridge-based nucleic amplification (CBNAAT)/GeneXpert test as a diagnostic modality for the detection of genital tuberculosis in women with infertility},
journal = {GMS Infectious Diseases},
year = {2025},
volume = {13},
number = {Doc03},
doi = {10.3205/id000093}
}
EUVIMED